1. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis;Skilton;Cochrane Database Syst Rev,2019
2. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del);Southern;Cochrane Database Syst Rev,2020
3. Worldwide rates of diagnosis and effective treatment for cystic fibrosis;Guo;J Cyst Fibros,2022
4. Current prices versus minimum costs of production for CFTR modulators;Guo;J Cyst Fibros,2022
5. http://www.genet.sickkids.on.ca – accessed August 2022